0
selected
-
1.
Reduced insulin need in patients with type 2 diabetes mellitus (T2DM) with iron deficiency anemia treated with sucrosomial iron vs intravenous sodium ferrigluconate. Multicentric prospective study
Giordano G, Parente A, Gigli R, Magri M, Berardi G, Carabellese B, D’Amico F, Luciano L, Fratangelo R, Niro G, et al
Haematologica. 2016;101((s1)):848.. pb2134.
-
2.
Oral high dose liposomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulphate. Multicentric randomized study
Giordano G, A Parente A, Gigli R, Magri M, Berardi G, Carabellese B, d’Amico F, Luciano L, Fratangelo R, NiroG, et al
Haematologica. 2016;101((s1)):613.. e1484.
-
3.
Liposomial iron improves fatigue in patients with myelodysplastic syndromes as refractory anemia. Multicentric study
Giordano G, d'Amico F, Commatteo A, Berardi G, Berardi D, Carabellese B, Gigli R, Magri M, Licianci A, di Marzio L
Haematologica. 2015;100((S1)):777.. Abstract no. PB1984.
-
4.
Oral high dose liposomial iron support is safe, fast, well tolerated and cost-effective as intravenous iron in sideropenic anemia. Multicentric randomized study
Giordano G, d’Amico F, Commatteo A, Berardi G, Berardi D, Carabellese B, Gigli R, Magri M, Licianci A, di Marzio L
Haematologica. 2015;100((S1)):133.. Abstract no. P382.